Pretargeted delivery of PI3K/mTOR small-molecule inhibitor–loaded nanoparticles for treatment of non-Hodgkin’s lymphoma

por Au, Kin Man, Wang, Andrew Z., Park, Steven I.
Publicado 2020

Trispecific natural killer cell nanoengagers for targeted chemoimmunotherapy

por Au, Kin Man, Park, Steven I., Wang, Andrew Z.
Publicado 2020

High-Performance Concurrent Chemo-Immuno-Radiotherapy for the Treatment of Hematologic Cancer through Selective High-Affinity Ligand Antibody Mimic-Functionalized Doxorubicin-Encap...

por Au, Kin Man, Balhorn, Rod, Balhorn, Monique C., Park, Steven I., Wang, Andrew Z.
Publicado 2018